These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6754569)

  • 81. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
    Allgayer H; Aguirre-Ghiso JA
    APMIS; 2008; 116(7-8):602-14. PubMed ID: 18834405
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Origin of fibronectin type II (FN2) modules: structural analyses of distantly-related members of the kringle family idey the kringle domain of neurotrypsin as a potential link between FN2 domains and kringles.
    Ozhogina OA; Trexler M; Bányai L; Llinás M; Patthy L
    Protein Sci; 2001 Oct; 10(10):2114-22. PubMed ID: 11567102
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.
    Kobayashi H; Ohi H; Shinohara H; Sugimura M; Fujii T; Terao T; Schmitt M; Goretzki L; Chucholowski N; Jänicke F
    Br J Cancer; 1993 Mar; 67(3):537-44. PubMed ID: 8382511
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Interactions of a fluorescently labeled peptide with kringle domains in proteins.
    Balciunas A; Fless GM; Scanu AM; Copeland RA
    J Protein Chem; 1993 Feb; 12(1):39-43. PubMed ID: 8381284
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Kringle-kringle interactions in multimer kringle structures.
    Padmanabhan K; Wu TP; Ravichandran KG; Tulinsky A
    Protein Sci; 1994 Jun; 3(6):898-910. PubMed ID: 8069221
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Novel thrombolytic agents.
    Verstraete M; Lijnen HR
    Cardiovasc Drugs Ther; 1994 Dec; 8(6):801-11. PubMed ID: 7742258
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular cloning of human haptoglobin cDNA: evidence for a single mRNA coding for alpha 2 and beta chains.
    vander Straten A; Herzog A; Jacobs P; Cabezón T; Bollen A
    EMBO J; 1983; 2(6):1003-7. PubMed ID: 6688992
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.
    Verde P; Stoppelli MP; Galeffi P; Di Nocera P; Blasi F
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4727-31. PubMed ID: 6589620
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content.
    Belin D; Godeau F; Vassalli JD
    EMBO J; 1984 Aug; 3(8):1901-6. PubMed ID: 6541126
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.
    Andreasen PA; Nielsen LS; Grøndahl-Hansen J; Skriver L; Zeuthen J; Stephens RW; Danø K
    EMBO J; 1984 Jan; 3(1):51-6. PubMed ID: 6538482
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
    Vassalli JD; Dayer JM; Wohlwend A; Belin D
    J Exp Med; 1984 Jun; 159(6):1653-68. PubMed ID: 6374011
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor.
    Salerno G; Verde P; Nolli ML; Corti A; Szöts H; Meo T; Johnson J; Bullock S; Cassani G; Blasi F
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):110-4. PubMed ID: 6364130
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors.
    Blomquist MC; Hunt LT; Barker WC
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7363-7. PubMed ID: 6334307
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Folding autonomy of the kringle 4 fragment of human plasminogen.
    Trexler M; Patthy L
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2457-61. PubMed ID: 6302685
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 96. cDNA and gene nucleotide sequence of porcine plasminogen activator.
    Nagamine Y; Pearson D; Altus MS; Reich E
    Nucleic Acids Res; 1984 Dec; 12(24):9525-41. PubMed ID: 6096832
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.
    Ny T; Elgh F; Lund B
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5355-9. PubMed ID: 6089198
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Macro- and micro-stabilities of the kringle 4 domain from plasminogen. The effect of ligand binding.
    De Marco A; Motta A; Llinás M; Laursen RA
    Biophys J; 1985 Sep; 48(3):411-22. PubMed ID: 4041537
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
    Vassalli JD; Baccino D; Belin D
    J Cell Biol; 1985 Jan; 100(1):86-92. PubMed ID: 3880760
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Elastase digested urokinase (ED-UK).
    Sumi H; Kosugi T; Toki N; Mihara H
    Experientia; 1985 Dec; 41(12):1546-8. PubMed ID: 3852742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.